Latest Headlines

31. Bruker Introduces MBT Sepsityper Kit US IVD For Rapid And Affordable Identification Of Over 400 Microorganisms From Positive Blood Cultures 1/4/2021

    Bruker Corporation today announce US FDA clearance and the US launch of the MBT Sepsityper Kit US IVD for rapid microbial identification of more than 425 microorganisms from positive blood cultures on the MALDI BiotyperCASystem

32. Enzo Biochem Receives FDA Emergency Use Authorization For Testing Pooled Samples On Three Platforms Including Company’s Genflex™ Proprietary System For Detection Of Coronavirus SARS-CoV-2 1/4/2021

    Enzo Biochem, Inc. (NYSE:ENZ​) (“Enzo” or “The Company”), a leading biosciences and diagnostics company, announced today that it has received an expansion of its Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) authorizing the use of pooled samples containing up to five individual swab specimens with the Company’s AMPIPROBE® SARS-Cov-2 Test System utilizing tests on three different platforms including Enzo’s proprietary GENFLEX^™ automated high-throughput platform

33. Applied DNA Partners With CLEARED4 On Pooled COVID-19 Surveillance Testing Program 12/29/2020

    Applied DNA Sciences, Inc. (“Applied DNA” or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that its wholly-owned subsidiary, Applied DNA Clinical Laboratories, LLC (ADCL) has entered into a reseller and sales referral partnership with CLEARED4, a field-proven, New York-based provider of return-to-work health safety solutions

34. INEX Innovate's CORO™ Real-Time RT-PCR SARS-CoV-2 Kit For The Detection Of COVID-19 Obtains Singapore's Health Sciences Authority Provisional Authorisation 12/29/2020

    INEX Innovate Pte Ltd a Singapore based molecular diagnostics developer today announced that the Singapore Health Sciences Authority has issued provisional authorisation to the company's CORO™ Real-Time RT-PCR SARS-CoV-2 for the diagnosis of COVID-19

35. Instrumentation Laboratory Awarded Massachusetts Life Sciences Center Tax Incentive 12/29/2020

    Instrumentation Laboratory (IL), a Werfen Company, today announced their $374,860 Tax Incentive Award from the Massachusetts Life Sciences Center (MLSC), as part of the Life Sciences Tax Incentive Program

36. Bionano Customer Praxis Genomics Accredited By College Of American Pathologists, Completing First LDT In US For Constitutional Genetic Disorders That Uses Whole Genome Analysis With Saphyr As Alternative To Chromosomal Microarray And Karyotyping 12/29/2020

    Bionano Genomics, Inc. (Nasdaq: BNGO), announced today that Praxis Genomics, LLC received accreditation from the College of American Pathologists (CAP), making it the first CAP-accredited, CLIA-certified diagnostic lab in the United States to offer a laboratory developed test (LDT) based on whole genome analysis with Saphyr

37. Corning Receives Award From U.S. Department Of Defense And U.S. Department Of Health And Human Services For Products Supporting COVID-19 Testing 12/24/2020

    Corning Incorporated (NYSE: GLW) today announced it has received an $15 million award from the U.S. Department of Defense (DoD), in coordination with Department of Health and Human Services (HHS), for the domestic production of robotic pipette tips used in support of diagnostic testing for COVID-19

38. OraSure’s OMNIgene®·ORAL Device Included In EUA Amendment Granted To 3B BlackBio Biotech India For SARS-CoV-2 Test 12/24/2020

    OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-care diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services, today announced that its OMNIgene®

39. Todos Medical Announces Agreement To Supply Natural Wellness Clinics With COVID-19 Testing Products To Support Initiatives In The Commonwealth Of Kentucky 12/24/2020

    Todos Medical (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer’s disease, today announced that it has entered into a preferred vendor agreement to supply COVID-19 related testing products and services to Natural Wellness Clinics (“NWC”) for use in its efforts in testing the uninsured population in the Commonwealth of Kentucky

40. Microbix & Copan Italia Execute Strategic Agreement 12/24/2020

    Microbix Biosystems Inc. (TSX: MBX, OTCQB: MBXBF, Microbix®), a life sciences innovator and exporter, and Copan Italia S.p.A. (Copan®), the global leader in specimen collection technologies, announce their execution of a strategic agreement (Agreement) in relation to Microbix’s quality assessment products (QAPs™) and Copan’s flocked devices (FLOQ®)